ZA829247B - Anti-ulcer drugs - Google Patents

Anti-ulcer drugs

Info

Publication number
ZA829247B
ZA829247B ZA829247A ZA829247A ZA829247B ZA 829247 B ZA829247 B ZA 829247B ZA 829247 A ZA829247 A ZA 829247A ZA 829247 A ZA829247 A ZA 829247A ZA 829247 B ZA829247 B ZA 829247B
Authority
ZA
South Africa
Prior art keywords
alkyl
halo
alkylene
alkoxy
optionally substituted
Prior art date
Application number
ZA829247A
Other languages
English (en)
Inventor
Richard Paul Pioch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA829247B publication Critical patent/ZA829247B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Liquid Crystal Substances (AREA)
ZA829247A 1981-12-28 1982-12-15 Anti-ulcer drugs ZA829247B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33478481A 1981-12-28 1981-12-28

Publications (1)

Publication Number Publication Date
ZA829247B true ZA829247B (en) 1984-07-25

Family

ID=23308823

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA829247A ZA829247B (en) 1981-12-28 1982-12-15 Anti-ulcer drugs

Country Status (23)

Country Link
EP (1) EP0083186B1 (cs)
JP (1) JPS58118585A (cs)
KR (1) KR860000106B1 (cs)
AT (1) ATE34173T1 (cs)
AU (1) AU558153B2 (cs)
CA (1) CA1206151A (cs)
CS (1) CS235976B2 (cs)
DD (1) DD203720A5 (cs)
DE (1) DE3278473D1 (cs)
DK (1) DK574782A (cs)
ES (1) ES8403895A1 (cs)
FI (1) FI824407L (cs)
GB (1) GB2111995B (cs)
GR (1) GR78415B (cs)
HU (1) HU192951B (cs)
IE (1) IE54313B1 (cs)
IL (1) IL67496A (cs)
NZ (1) NZ202797A (cs)
PH (1) PH19797A (cs)
PL (1) PL239796A1 (cs)
PT (1) PT76004B (cs)
SU (1) SU1195906A3 (cs)
ZA (1) ZA829247B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468399A (en) * 1981-12-28 1984-08-28 Eli Lilly And Company 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
TW245716B (cs) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
RU2250767C1 (ru) * 2004-07-12 2005-04-27 Казанский государственный медицинский университет Способ лечения язвенной болезни желудка и двенадцатиперстной кишки
CN102260254A (zh) * 2010-05-31 2011-11-30 中国农业科学院植物保护研究所 新颖2-硝基亚氨基嘧啶衍生物的合成

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
IN146736B (cs) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
EP0083186B1 (en) 1988-05-11
EP0083186A3 (en) 1984-05-23
KR840002831A (ko) 1984-07-21
FI824407A7 (fi) 1983-06-29
JPS58118585A (ja) 1983-07-14
IE823031L (en) 1983-06-28
PT76004A (en) 1983-01-01
ATE34173T1 (de) 1988-05-15
PL239796A1 (en) 1984-05-21
GR78415B (cs) 1984-09-27
IL67496A (en) 1986-11-30
EP0083186A2 (en) 1983-07-06
IE54313B1 (en) 1989-08-16
DD203720A5 (de) 1983-11-02
PT76004B (en) 1985-12-03
CS235976B2 (en) 1985-05-15
KR860000106B1 (ko) 1986-02-19
AU9153982A (en) 1983-07-07
PH19797A (en) 1986-07-02
GB2111995A (en) 1983-07-13
GB2111995B (en) 1985-07-24
FI824407L (fi) 1983-06-29
HU192951B (en) 1987-08-28
CA1206151A (en) 1986-06-17
NZ202797A (en) 1985-08-30
SU1195906A3 (ru) 1985-11-30
DK574782A (da) 1983-06-29
ES518592A0 (es) 1984-04-01
DE3278473D1 (en) 1988-06-16
AU558153B2 (en) 1987-01-22
FI824407A0 (fi) 1982-12-21
ES8403895A1 (es) 1984-04-01

Similar Documents

Publication Publication Date Title
ES8405782A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
ES527954A1 (es) Un procedimiento para preparar isoxazoles
FI93351C (fi) Menetelmä terapeuttisesti käyttökelpoisten polyetyleeniglykolikarbaminaattien valmistamiseksi
DE3262698D1 (en) Antifibrinolytically active compounds
ZA834710B (en) Substituted azolyl-ketones and-alcohols
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
AU558153B2 (en) Pyrimidine derivatives of 1,3-thiazole
FI923774A0 (fi) 1,7-anellerande 2-(piperazinoalkyl) indolderivat samt foerfaranden och mellanprodukter foer deras framstaellning.
ES2068413T3 (es) Derivados de 4-fenilftalazina.
ATE38028T1 (de) Cycloaliphatische heilmittelzusammensetzungen.
ES8801619A1 (es) Procedimiento para la obtencion de n-6-metoxi-5(perfluoroal-quil)-1-naftoil-n-metilglicinas y sus analogos tionaftoili- cos
ES8704908A1 (es) Procedimiento para la obtencion de derivados de azolilciclo-propilazometil-carbinol sustituidos
MY102760A (en) New surfactants.
DE3864336D1 (en) Aromatische thioaether.
GR860118B (en) Substituted furazane
ES8503646A1 (es) Procedimiento para la obtencion de derivados de bencilurea.
GR77953B (cs)